Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000892569-03-002578
Filing Date
2003-11-12
Accepted
2003-11-12 17:28:39
Documents
7
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTER ENDED SEPTEMBER 30, 2003 a94433e10vq.htm 10-Q 839998
3 EXHIBIT 3.1 a94433exv3w1.htm EX-3.1 81580
4 EXHIBIT 15.1 a94433exv15w1.htm EX-15.1 3074
5 EXHIBIT 15.2 a94433exv15w2.htm EX-15.2 1671
6 EXHIBIT 31.1 a94433exv31w1.htm EX-31.1 6287
7 EXHIBIT 31.2 a94433exv31w2.htm EX-31.2 6145
8 EXHIBIT 32.1 a94433exv32w1.htm EX-32.1 3606
  Complete submission text file 0000892569-03-002578.txt   944764
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11397 | Film No.: 03995078
SIC: 2834 Pharmaceutical Preparations